(Q36666331)

15 August 2017

1 reference

title

Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection (English)

1 reference

15 August 2017

1 reference

1 reference

Jeffrey J Post

3

0 references

William D. Rawlinson

object named as

William D Rawlinson

5

0 references

Andrew R. Lloyd

object named as

Andrew R Lloyd

1

0 references

author name string

Emma Jagger

2

1 reference

15 August 2017

Lee-Ann Crooks

4

1 reference

15 August 2017

Young S Hahn

6

1 reference

15 August 2017

Rosemary A Ffrench

7

1 reference

15 August 2017

publication date

28 November 2006

1 reference

Immunology & Cell Biology

15 August 2017

published in

1 reference

15 August 2017

volume

85

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

24-32

1 reference

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

The natural history of chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of human intravenous immunoglobulin in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Immunity in hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Unscrambling hepatitis C virus-host interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Comparative features of hepatitis C virus infection in humans and chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Unravelling hepatitis C virus replication from genome to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Robust hepatitis C virus infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Complete replication of hepatitis C virus in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Structural biology of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

A target on the move: innate and adaptive immune escape strategies of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Nucleotide sequence and mutation rate of the H strain of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Challenges and successes in developing new therapies for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

In search of hepatitis C virus receptor(s).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

CD81 is an entry coreceptor for hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Histopathology and detection of hepatitis C virus in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Gene expression profile of T-cell-specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Intrahepatic CD4+ cell depletion in hepatitis C virus/HIV-coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Viruses and interferon: a fight for supremacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

21 January 2018

Viruses and interferons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Toll-like receptors in the pathogenesis of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Introduction of replication-competent hepatitis C virus transcripts using a tetracycline-regulable baculovirus delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Nf-kappa B, chemokine gene transcription and tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Evasion of intracellular host defence by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Immunology of hepatitis B virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Protective immunity against hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Cell-mediated immunity and the outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Determinants of viral clearance and persistence during acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Immune responses in hepatitis C: is virus or host the problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Detection of functionally altered hepatitis C virus-specific CD4+ T cells in acute and chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

T cell response in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Analysis of successful immune responses in persons infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Analysis of a successful immune response against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Cytotoxic T-cell memory without antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Response of naïve and memory CD8+ T cells to antigen stimulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

On differences between immunity and immunological memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Detection and Analysis of Hepatitis C Virus Sequences in Cerebrospinal Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Central nervous system involvement in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Restoring function in exhausted CD8 T cells during chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Protection against persistence of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Detection of hepatitis C core antigen in the antibody negative 'window' phase of hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Limited humoral immunity in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Clinical evaluation of titration of hepatitis C virus core antibody and its subclasses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Neutralizing antibody response during acute and chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Inducible nitric oxide synthase gene (NOS2A) haplotypes and the outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Genetic variations in humans associated with differences in the course of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Clearance of hepatitis C virus is not associated with single nucleotide polymorphisms in the IL-1, -6, or -10 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

MHC class II genes influence the susceptibility to chronic active hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self-limited hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Association between human leukocytes antigen alleles and chronic hepatitis C virus infection in the Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Racial differences in HLA class II associations with hepatitis C virus outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

HLA-Cw*04 and hepatitis C virus persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

HLA association with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Persistence of hepatitis C virus in a white population: associations with human leukocyte antigen class 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Host genetic determinants in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Association between MHC Class II Alleles and Clearance of Circulating Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Immunopathogenesis of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

Detection and distribution of hepatitis C—specific antigens in naturally infected liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

7 January 2021

Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

7 January 2021

CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

7 January 2021

Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

7 January 2021

Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

7 January 2021

Cutting edge: emergence of CD127high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

7 January 2021

Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

7 January 2021

On immunological memory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

7 January 2021

Humoral immunity in acute and chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

7 January 2021

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

7 January 2021

Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

7 January 2021

HLA class II favors clearance of HCV infection and progression of the chronic liver damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

7 January 2021

HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

7 January 2021

The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100010

7 January 2021

Identifiers

DOI

10.1038/SJ.ICB.7100010

1 reference

15 August 2017

1 reference